Review: taking Methadose and Remeron together


Summary

Drug interactions are reported among people who take Methadose and Remeron together. This review analyzes the effectiveness and drug interactions between Methadose and Remeron. It is created by eHealthMe based on reports of 882 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Methadose

Methadose has active ingredients of methadone hydrochloride. It is often used in drug abuse. (latest outcomes from Methadose 3,127 users)

Remeron

Remeron has active ingredients of mirtazapine. It is often used in depression. (latest outcomes from Remeron 16,341 users)

On Sep, 17, 2016

882 people who take Methadose, Remeron are studied.


Number of reports submitted per year:

Methadose and Remeron drug interactions.

Drug effectiveness over time:

Methadose:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 100.0% - (2 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 100.0% - (4 of 4 people)
  • 2 - 5 years: 0.0% - (0 of 2 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Remeron:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 50.0% - (1 of 2 people)
  • 1 - 2 years: 0.0% - (0 of 2 people)
  • 2 - 5 years: 50.0% - (1 of 2 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Methadose:
  • female: 57.0% - (4 of 7 people)
  • male: 50.0% - (3 of 6 people)
Remeron:
  • female: 40.0% - (2 of 5 people)
  • male: 14.0% - (1 of 7 people)

Drug effectiveness by age:

Methadose:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 50.0% - (1 of 2 people)
  • 30-39: 71.0% - (5 of 7 people)
  • 40-49: 50.0% - (1 of 2 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 0 people)
Remeron:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 0.0% - (0 of 3 people)
  • 30-39: 40.0% - (2 of 5 people)
  • 40-49: 50.0% - (1 of 2 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • somnolence
  • headache
  • delirium
  • dizziness
  • fatigue
  • lung neoplasm malignant
  • pain
  • back pain
  • contusion
  • death
1 - 6 months:
  • dyspnoea
  • nausea
  • somnolence
  • vomiting
  • drug ineffective
  • swelling
  • abdominal distension
  • abdominal pain
  • abortion spontaneous
  • activation syndrome
6 - 12 months:
  • nausea
  • drug withdrawal syndrome neonatal
  • pain
  • asthenia
  • atrial septal defect
  • dizziness postural
  • electrocardiogram qt prolonged
  • lethargy
  • neonatal respiratory distress syndrome
  • orthostatic hypotension
1 - 2 years:
  • electrocardiogram qt prolonged
  • activities of daily living impaired
  • cardiac arrest
  • faecal incontinence
  • torsade de pointes
  • urinary incontinence
  • ventricular fibrillation
  • drug level above therapeutic
  • encephalopathy
  • feeling abnormal
2 - 5 years:
  • abnormal behaviour
  • amnesia
  • anxiety
  • aphonia
  • chronic fatigue syndrome
  • cough
  • diabetes mellitus inadequate control
  • dissociative fugue
  • dizziness
  • drowsiness
5 - 10 years:
  • depression
  • abdomen - swollen
  • breathlessness
  • cervical dysplasia
  • coma
  • constipation
  • human papilloma virus (hpv)
  • initial insomnia
  • panic attacks
  • pitting oedema
10+ years:
  • depression
  • abdomen - swollen
  • breathlessness
  • cardiac arrest
  • coma
  • constipation
  • initial insomnia
  • panic attacks
  • pitting oedema
  • polytraumatism
not specified:
  • fatigue
  • pain
  • dyspnoea
  • anxiety
  • nausea
  • asthenia
  • constipation
  • vomiting
  • back pain
  • anaemia

Most common drug interactions by gender *:

female:
  • pain
  • anxiety
  • nausea
  • fatigue
  • dyspnoea
  • back pain
  • constipation
  • asthenia
  • headache
  • hypoaesthesia
male:
  • vomiting
  • fatigue
  • diarrhoea
  • weight decreased
  • asthenia
  • nausea
  • pain
  • anaemia
  • constipation
  • pneumonia

Most common drug interactions by age *:

0-1:
  • drug withdrawal syndrome neonatal
  • neonatal respiratory distress syndrome
  • foetal exposure during pregnancy
  • atrial septal defect
  • coarctation of the aorta
  • patent ductus arteriosus
  • small for dates baby
  • cardiac failure
  • bradypnoea
  • feeding disorder neonatal
10-19:
  • drug screen positive
  • extrapyramidal disorder
  • somnolence
  • accidental overdose
  • drug toxicity
  • drug ineffective
  • intentional overdose
  • multiple drug overdose
  • overdose
  • suicide attempt
20-29:
  • dyskinesia
  • dystonia
  • grand mal convulsion
  • oculogyric crisis
  • respiratory failure
  • convulsion
  • brain damage
  • cardiac arrest
  • drug abuser
  • agitation
30-39:
  • dyspnoea
  • drug abuse
  • convulsion
  • sedation
  • anxiety
  • influenza like illness
  • nausea
  • death
  • drug dependence
  • constipation
40-49:
  • nausea
  • pneumonia
  • asthenia
  • anaemia
  • urinary tract infection
  • dyspnoea
  • pain
  • pyrexia
  • vomiting
  • fatigue
50-59:
  • fatigue
  • pain
  • constipation
  • anxiety
  • arthralgia
  • emotional distress
  • exostosis
  • injury
  • intervertebral disc protrusion
  • pain in extremity
60+:
  • fall
  • nausea
  • back pain
  • death
  • fatigue
  • pain
  • somnolence
  • malaise
  • dizziness
  • withdrawal syndrome

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Methadose and Remeron?

Can you answer these questions?

More questions for: Methadose, Remeron

You may be interested in these reviews

More reviews for: Methadose, Remeron

On eHealthMe, Methadose (methadone hydrochloride) is often used to treat drug abuse. Remeron (mirtazapine) is often used to treat depression. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.